Page 131 - 00. Complete Version - Progress Report IPEN 2014-2016

Radiopharmacy | Progress Report 131

201
CARD-IPEN Tl - Thallium chloride DOT-IPEN-177 177 Lu-DOTATATE (DOTA-Oct-
For cardiac function studies. reotate)
Therapeutic agent for neuroendocrine tumors.
32
FOSFATO DE SÓDIO-32 P – Sodium phos-
phate OCT-IPEN In-DTPA-TOC (DTPA-Octreotide)
111
Used in treatment of polycythaemia vera and Diagnostic agent for neuroendocrine tumors.
biotechnology.
LID-IPEN I-Lipiodol – (Lipiodol)
131
35
SULFATO DE SÓDIO-35 S - Sulphuric acid Treatment of hepatocellular carcinoma (HCC),
Used in metabolic investigation. the selective retention suggests its poten-
tial as chemotherapeutic or radiotherapeu-
18
FLUR-IPEN F – Sodium Fluoride tic agents.
Used in bone image in PET and PET-CT.
GUAN-IPEN-123 123I-MIBG - (Meta-iodo-
benzylguanidine)
B Labeled compounds Diagnosis of pheochromocytoma, neuroblas-

toma and myocardial studies.

SAMAR-IPEN 153 Sm-EDTMP - (ethylenedi- HIPUR-IPEN 131I-Hippurate – (o-iodo-hip-
amine-tetramethylene-phosphonic acid) purate)
Therapeutic agent indicated for relief of pain Used for the investigation of kidney function,
in patients with confirmed osteoblastic met- gives information about the renal blood flow,
astatic bone lesions in breast and prostate urinary tract potency and urinary flow in nu-
cancer. clear medicine.

GUAN-IPEN-131 I-MIBG – (Meta-iodoben- ALB-IPEN-131 131I-HSA – (Human serum
131
zylguanidine) albumin)
Diagnostic and therapeutic agent of neural For determination of plasma volume and to-
crest-derived tumors. tal blood volume.

177 Lu-Dotatate

Doses
Figure 6 - Distribution of Lu - Dotatate 331
177
295
243 220 253 230
176

2010 2011 2012 2013 2014 2015 2016